Avitar Selected to Present at ASSE National Conference
08 9월 2006 - 12:24AM
PR Newswire (US)
CANTON, Mass., Sept. 7 /PRNewswire-FirstCall/ -- Avitar, Inc.
(OTC:AVTI.OB) (BULLETIN BOARD: AVTI.OB) , developer of the world's
first rapid, on-site, oral fluid-based screening test for
drugs-of-abuse, will be a featured presenter at a national audio
technical conference under the auspices of the American Society of
Safety Engineers (ASSE), the nation's largest and oldest
professional safety organization with more than 30,000 members, on
Wednesday, September 20th, from 11:00 AM to 12:30 PM (CT). The
conference, entitled Issues and Implications of Drug Abuse &
Examining the Need for Drug Testing, will review the current
methods of drug testing, their benefits and drawbacks, as well as
discuss the operational, legal and economic considerations of an
effective drug-free workplace testing program. "Following our
presentation at the ASSE National Conference in Seattle in June, we
are again honored to have been chosen to address Safety, Health and
Environmental professionals across the United States. The ASSE
clearly recognizes that impairment by drug or alcohol use
constitutes avoidable workplace hazards and costs," said Peter P.
Phildius, Avitar's Chief Executive Officer. "Our advocacy for
random drug testing, as a critical element in an effective
drug-free workplace program, is being recognized by those most
concerned with improving worker safety and health." "ASSE is
excited to host this important call and we have received a lot of
initial interest from our members," said Tim Fisher, ASSE Director,
Practices and Standards. "We are thrilled that we have this
opportunity to host some of the leading experts in the field of
drug abuse and we look forward to a very fruitful and enlightening
discussion." Additional information regarding the conference can be
found at http://www.asse.org/drugtestingsupport/. ABOUT AVITAR
Avitar, Inc. develops, manufactures and markets innovative and
proprietary products. Their field includes the oral fluid
diagnostic market, the disease and clinical testing market, and
customized polyurethane applications used in the wound dressing
industry. Avitar manufactures ORALscreen(R), the world's first
non-invasive, rapid, onsite oral fluid test for drugs-of-abuse, as
well as HYDRASORB(R), an absorbent topical dressing for moderate to
heavy exudating wounds. Avitar is also developing diagnostic
strategies for disease and clinical testing in the estimated $25
billion in-vitro diagnostics market. Conditions targeted include
influenza, diabetes, and pregnancy. For more information, see
Avitar's website at http://www.avitarinc.com/. ABOUT ASSE Founded
in 1911, the Des Plaines, IL-based ASSE is the largest and oldest
professional safety organization and is committed to protecting
people, property and the environment. It has more than 30,000
occupational safety, health and environmental professional members
who manage, supervise research and consult on safety, health,
transportation and environmental issues in all industries,
government, labor and education. For more information check ASSE's
website at http://www.asse.org/. Safe Harbor Statement This release
contains forward looking statements that are subject to risks and
uncertainties including the development and marketing of new
applications and other risks that are detailed from time to time in
the Company's filings with the Securities and Exchange Commission.
In view of such risks and uncertainties, the Company's actual
results could differ materially from those anticipated in such
forward looking statements. Contact: Jay C. Leatherman Avitar Inc.
781-821-2440 http://www.avitarinc.com/ The Investor Relations Group
Investors: Erika Moran / Tom Caden, 212-825-3210 Media: Lynn
Granito / Susan Morgenbesser, 212-825-3210 DATASOURCE: Avitar, Inc.
CONTACT: Jay C. Leatherman of Avitar Inc., +1-781-821-2440; or
(Investors) Erika Moran, +1-212-825-3210, or Tom Caden,
+1-212-825-3210, , both of The Investor Relations Group; or (Media)
Lynn Granito, +1-212-825-3210, or Susan Morgenbesser,
+1-212-825-3210, Web site: http://www.avitarinc.com/
http://www.asse.org/drugtestingsupport
Copyright